Company: DMAC
Filing Date: 2025-12-18
Form Type: 8-K
Source: 0001437749-25-038211
Chunk: 0

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-12-18
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01

Regulation FD Disclosure.

On December 18, 2025, DiaMedica Therapeutics Inc. provided a DM199 preeclampsia program update following its pre-IND meeting with the United States Food and Drug Administration (FDA). The text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information contained in this Item 7.01 and Exhibit 99.1 to this report shall not be deemed to be “filed” with the United States Securities and Exchange Commission for purposes of Section 18 of the United States Securities Exchange Act of 1934, as amended (the “ Exchange Act”), and shall not be incorporated by reference into any filings made by the DiaMedica under the Securities Act of 1933, as amended, or the Exchange Act, except as may be expressly set forth by specific reference in such filing.

Item 8.01Other Events.